Niro Ramachandran - Mar 23, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Signature
/s/ Niro Ramachandran, Ph.D., by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Mar 23, 2022
Transactions value $
$0
Form type
4
Date filed
3/25/2022, 07:24 PM
Previous filing
Nov 22, 2021
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Award +22.5K +89.74% 47.6K Mar 23, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Employee Stock Option (Right to Buy) Award $0 +45K $0.00 45K Mar 23, 2022 Common Stock 45K $11.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units shall vest in four (4) equal annual installments beginning on the first anniversary of the grant date and on each anniversary thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
F3 The options shall vest as follows: twenty-five percent (25%) shall vest on the first anniversary of the grant date with the remainder vesting in 36 equal monthly installments beginning on April 23, 2023.